Human Recombinant IL-37, STEMCELL Technologies (CAT#: STEM-CT-0766-ZJF)

Use Interleukin 37 (IL-37) to inhibit the expression of inflammatory cytokines, such as IL-6, MIP-1α, MIP-1β, and TNF-α, in a MAPK-dependent manner (Qi et al.). A secreted protein belonging to the interleukin-1 cytokine family, IL-37 acts as an anti-inflammatory alarmin, with predominant expression in monocytes, and constitutive secretion by myeloid dendritic cells (Rudloff et al.). IL-37 has been shown to limit inflammation in human blood M1 macrophages by binding to extracellular surface receptors, requiring IL-1R8 as a coreceptor (Li et al.). It also has protective effects against obesity-induced inflammation and insulin resistance, reducing adipogenesis and activating AMPK signaling both in vitro and in vivo (Ballak et al.). In humans, the IL-37 gene undergoes alternative splicing, resulting in multiple isoforms of the protein (Boraschi et al.). For consistency and reproducibility across your applications, Interleukin 37 from STEMCELL comes lyophilized with ≥ 93% purity.

Subtype: Cytokines
Alternatives Names: FIL1, FIL1(ZETA), FIL1Z, IL1F7, IL-1F7, IL-1H, IL1H4, IL-1H4, IL1RP1, IL-1RP1, IL37
Species: Human
Area of Interest: Metabolism
Purity: ≥ 93%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant Apolipoprotein A-I, STEMCELL Technologies
Human Recombinant ANGPTL2, STEMCELL Technologies
Human Recombinant Sclerostin, STEMCELL Technologies
Human Recombinant Hepassocin, STEMCELL Technologies